ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — MacroGenics Inc. (MGNX) on Thursday reported a loss of $36.3 million in its second quarter.
The Rockville, Maryland-based company said it had a loss of 57 cents per share.
The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 59 cents per share.
The biopharmaceutical company posted revenue of $22.2 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $21.2 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MGNX at https://www.zacks.com/ap/MGNX
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
